Press Releases

Print Print page     Email Email page

= Add Release to Briefcase
All Releases
View Summary United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014
Jul 22, 2014
PDF 7.7 KB Add to Briefcase
View Summary United Therapeutics Announces Additional $500 Million Share Repurchase Program
Jun 27, 2014
PDF 8.7 KB Add to Briefcase
View Summary Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize Transplantation Field
May 6, 2014
PDF 11.8 KB Add to Briefcase
View Summary United Therapeutics Corporation Reports First Quarter 2014 Financial Results
Apr 29, 2014
PDF 22.5 KB Add to Briefcase
View Summary United Therapeutics Corporation To Announce First Quarter 2014 Financial Results Before Market Open On Tuesday, April 29, 2014
Apr 22, 2014
PDF 7.7 KB Add to Briefcase
View Summary Japan's Ministry of Health, Labour and Welfare Grants Approval for United Therapeutics' Remodulin
Mar 26, 2014
PDF 11.8 KB Add to Briefcase
View Summary United Therapeutics Corporation Reports 2013 Fourth Quarter and Annual Financial Results
Feb 25, 2014
PDF 472.4 KB Add to Briefcase
View Summary United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014
Feb 18, 2014
PDF 7.7 KB Add to Briefcase
View Summary FDA Approves Orenitram™ (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension
Dec 20, 2013
PDF 13.4 KB Add to Briefcase
View Summary United Therapeutics Receives Subpoena From Office of Inspector General
Dec 9, 2013
PDF 8.2 KB Add to Briefcase
View Summary United Therapeutics Corporation Reports Third Quarter 2013 Financial Results
Oct 29, 2013
PDF 24.9 KB Add to Briefcase
View Summary United Therapeutics Corporation to Announce Third Quarter 2013 Financial Results Before Market Open on Tuesday, October 29, 2013
Oct 22, 2013
PDF 7.7 KB Add to Briefcase
View Summary United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA
Sep 11, 2013
PDF 8.0 KB Add to Briefcase
View Summary United Therapeutics Corporation Reports Second Quarter 2013 Financial Results
Jul 25, 2013
PDF 24.6 KB Add to Briefcase
View Summary United Therapeutics Corporation to Announce Second Quarter 2013 Financial Results Before Market Open on Thursday, July 25, 2013
Jul 18, 2013
PDF 7.7 KB Add to Briefcase
View Summary United Therapeutics Corporation Reports First Quarter 2013 Financial Results
Apr 25, 2013
PDF 23.0 KB Add to Briefcase
View Summary United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
Apr 18, 2013
PDF 7.7 KB Add to Briefcase
View Summary United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
Mar 25, 2013
PDF 8.4 KB Add to Briefcase
View Summary United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
Feb 26, 2013
PDF 338.5 KB Add to Briefcase
View Summary United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
Feb 19, 2013
PDF 7.6 KB Add to Briefcase
Showing 1-20 of 236 releases Page: 1 2 3 4 5 6 7 8 9 10 11 12  See Next 20

United Therapeutics' Press Release Archive is furnished solely for historical purposes. Statements made in any release posted here speak only as of the date of such release. We do not undertake any obligation to update any information contained in any release. Our business, financial condition, results of operations and prospects may have changed since the date of any release posted here.